Taerim Pharmaceutical Co., Ltd.

Taerim Pharmaceutical Co., Ltd.—now operating as Pharmaking Co., Ltd.—is an established Korean pharmaceutical/biotech firm specializing in innovative treatments for viral hepatitis using both synthetic small molecules and patented compounds derived from natural sources. Its flagship products include Nissel and Pennel—both leading anti-hepatitis medications in South Korea—with Pennel exported internationally. The company remains active with ongoing R&D efforts targeting additional adult diseases through novel therapeutics based on its expertise in both traditional pharmaceuticals and naturally sourced compounds. It operates independently under CEO Kim Wan Bae without evidence of acquisition or parent/subsidiary relationships.[4]